• When pharmacology meets the microbiome: new targets for therapeutics? 

  Hyland, Niall P.; Cryan, John F. (British Pharmacological Society, 2018-11-26)
• Caffeine therapy for apnoea of prematurity: wake up to the fact that sex matters 

  McDonald, Fiona B.; Dempsey, Eugene M.; O'Halloran, Ken D. (John Wiley & Sons, Inc., 2018-08-02)
• The shape of things to come: early life stress stunts brainstem microglia with lasting implications for cardiorespiratory control and plasticity 

  O'Halloran, Ken D.; McDonald, Fiona B. (John Wiley & Sons, Inc., 2018-07-11)
• Brainstem network pathology and impaired respiratory drive as successive signatures in a rat model of Parkinson's disease 

  Burns, David P.; O'Halloran, Ken D. (John Wiley & Sons, Inc., 2018-08-25)
• Bioaccessibility and bioavailability of a marine-derived multimineral, Aquamin-Magnesium 

  Felice, Valeria D.; O'Gorman, Denise M.; O'Brien, Nora M.; Hyland, Niall P. (MDPI AG, 2018)

  Introduction: Magnesium is an essential mineral involved in a range of key biochemical pathways. Several magnesium supplements are present on the market and their degree of bioavailability differs depending on the form of ...

View more